← SynDRA
ANTINEOPLASTON A10
SynDRA canonical compound SYN0028856 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | DPM1 | LGALS1 |
| Mechanism of action | p53 activator |
| Indication | brainstem glioma |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Antineoplaston a 10
- Atengenal
- Antineoplaston A-10
- Antineoplaston A-10, Burzynski Institute
- Antineoplaston A 10
- N-[(3S)-2,6-dioxopiperidin-3-yl]-2-phenylacetamide
- atengenal
- 3-(N-Phenylacetylamino)-2,6-piperidinedione
- N-(2,6-Dioxo-3-piperidinyl)benzeneacetamide
- 3-((Phenylacetyl)amino)-2,6-piperidinedione
- NSC619130
- Benzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-
- BENZENEACETAMIDE, N-((3S)-2,6-DIOXO-3-PIPERIDINYL)-
- N-((3S)-2,6-dioxopiperidin-3-yl)-2-phenylacetamide
- NSC377381
- RefChem:916000
- 3-phenylacetylamino-2, 6-piperidinedione
- 3-Phenylacetylamino-2,6-piperidinedione
- MFCD26961095
- (S)-N-(2,6-Dioxopiperidin-3-yl)-2-phenylacetamide
- N-[(3s)-2,6-dioxo-3-piperidyl]-2-phenyl-acetamide
- A-10
- UNII-16VY3TM7ZO
- Cengenal
- AntineoplastonA10
- Antineoplaston A10 capsules
- ANP-A10
- A10
- orb1300042
- SCHEMBL20772654
- US11802131, Example 1
- BDBM631074
- EBC-66084
- AKOS040759084
- ANTINEOPLASTON A 10 [WHO-DD]
- NSC 620261
- NSC-619130
- AS-84380
Look up ANTINEOPLASTON A10 in the interactive SynDRA portal →